Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
💎 Access the Market Tools Trusted by Thousands of Investors Get Started
Close

Pfizer Inc (PFE)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
135,300.00 0.00    0.00%
13/09 - Delayed Data. Currency in COP ( Disclaimer )
Type:  Equity
Market:  Colombia
ISIN:  US7170811035 
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 135,300.00 - 135,300.00
Pfizer 135,300.00 0.00 0.00%

Pfizer Inc Company Profile

 
Get an in-depth profile of Pfizer Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

83000

Equity Type

ORD

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women’s health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc., as well as strategic partnership with CSPC Pharmaceutical Group Limited to launch a local brand of the COVID-19 oral therapeutic treatment Nirmatrelvir/Ritonavir in China, and a collaboration with Carrick Therapeutics Limited. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Contact Information

Address 66 Hudson Boulevard East
New York, 10001-2192
United States
Phone 212 733 2323
Fax -
Web www.pfizer.com

Top Executives

Name Age Since Title
Charles T. Hagel 77 - Member of Emerging Markets Advisory Board
Shantanu Narayen 59 2013 Lead Independent Director
Albert Bourla 61 2016 Chairman of the Board & CEO
Joseph J. Echevarria 66 2015 Independent Director
Helen H. Hobbs 71 2011 Independent Director
Suzanne M. Nora Johnson 66 2007 Independent Director
James C. Smith 63 2014 Independent Director
Daniel R. Littman 70 2018 Independent Director
Susan Desmond-Hellmann 66 2020 Independent Director
Scott Gottlieb 50 2019 Independent Director
James Robert B. Quincey 58 2020 Independent Director
Ronald E. Blaylock 63 2017 Independent Director
Susan J. Hockfield 71 2020 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

PFE Comments

Write your thoughts about Pfizer Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
DYLAN VURBIER
DYLAN VURBIER 4 hours ago
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
It is good to invest in Pfizer now
Reply
1 1
Report
DYLAN VURBIER
DYLAN VURBIER 4 hours ago
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
?
Reply
0 0
Report
Jay Clerk
Jay Clerk Sep 28, 2023 1:35PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Tanking again and again beautiful!
Reply
2 0
Report
sayed Elsayed
sayed Elsayed Sep 27, 2023 1:19PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This stock is Collapsing
Reply
2 1
Report
Jay Clerk
Jay Clerk Sep 27, 2023 1:19PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Just wait for earnings then it will ve to late to get out! Proud bagholder
Reply
0 0
Report
George Galloway
George Galloway Sep 22, 2023 1:41PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
sad company with zero leadership and zero vision.
Reply
4 1
Report
damian del
mudlog79 Sep 22, 2023 10:44AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
dump this trash
Reply
2 1
Report
Hisham Chehab
Hisham Chehab Sep 21, 2023 2:20PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Can anyone provide a good vision for this stock plz.
Reply
0 2
Report
Thị Mỹ Thuận Trần
Thị Mỹ Thuận Trần Sep 21, 2023 2:20PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
30 $ soon
Reply
1 1
Report
Crim Jamer
Crim Jamer Sep 21, 2023 2:20PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Just believe what you see. I bought calls on last friday, they are almost total loss now.
Reply
0 0
Report
Jay Clerk
Jay Clerk Sep 21, 2023 2:20PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
If you get your bews from the mainstream then your bound to ve a victim , you just wont get it . Been shorting since 52$ havent let up once its going to 20s! This company is run by satan!
Reply
0 0
Report
Jay Clerk
Jay Clerk Sep 18, 2023 6:23PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Poopiest stock that ever circled the toilet
Reply
5 1
Report
George Galloway
George Galloway Sep 13, 2023 1:45PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
change at CEO is very much needed
Reply
5 0
Report
liebe dich ich
liebe dich ich Sep 13, 2023 6:05AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
wtf Pfizer stock? CEO should retire and get down his salary!
Reply
3 0
Report
Jay Clerk
Jay Clerk Sep 12, 2023 6:48AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Nobody with common sense will be getting another death jabbed. You have to be crazy to put that poisen in your viens
Reply
4 8
Report
aux fipe
aux fipe Sep 12, 2023 6:48AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Hooked on Phonics is a great tool.
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email